Tumor necrosis factor-alpha in patients with alopecia areata

Indian Journal of Dermatology

Volumn 56, Issue 5, 2011, Pages 494-496

  Kasumagic Halilovic, Emina ^a   Prohic, Asja ^a   Cavaljuga, Semra ^b  

^a KLINICKI CENTAR UNIVERZITETA U SARAJEVU   (Bosnia and Herzegovina)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Alopecia areata; immunoassay; tumor necrosis factor alpha

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALOPECIA; ALOPECIA AREATA; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAIR FOLLICLE; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; SCALP HAIR; SERUM; T LYMPHOCYTE;

EID: 81255141116     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.87124     Document Type: Article

References (18)

1. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton IJ. Incidence of alopecia areata in Olmsted Country, Minesota, 1975-1989. Mayo Clin Proc 1995;70:628-33.
2. Alexis AF, Dudda-Subramanya R, Sinha A. Alopecia areata: Autoimmune basis of hair loss. Eur J Dermatol 2004;14:364-70. (Pubitemid 39551596)
3. Bodemer C, Peuchmaur M, Fraitag S, Chatenoud L, Brousse N, De Prost Y. Role of cytotoxic T cells in chronic alopecia areata. J Invest Dermatol 2000;114:112-6. (Pubitemid 30195982)
4. Symington FW. Lymphotoxin, tumor necrosis factor, and gamma interferon are cytostatic for normal human keratinocytes. J Invest Dermatol 1989;92:798-805. (Pubitemid 19166604)
5. Roussaki-Schulze AV, Kouskoukis C, Petinaki E, Klimi E, Zafiriou E, Galanos A, et al. Evaluation of cytokine serum levels in patients with plaque-type psoriasis. Int J Pharmacol Res 2005;25:169-73. (Pubitemid 41810112)
6. Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNFalpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005;5:273-9. (Pubitemid 41577417)
7. Gomez D, Correa PA, Gomez LM, Cadena J, Molina JF, Anaya JM. Th1/Th2 cytokines in patients with systemic lupus erythematosus: Is tumor necrosis factor alpha ptotective? Semin Arthritis Rheum 2004;33:404-13.
8. Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol 1999;40:242-6. (Pubitemid 29072802)
9. Hoffmann R. The potential role of cytokines and T cells in alopecia areta. J Investig Dermatol Symp Proc 1999;4:235-8.
10. Eckert J, Church RE, Ebling FJ. The pathogenesis of alopecia areata. Br J Dermatol 1968;80:203-10.
11. del Rio E. Targetoid hair regrowth in alopecia areata: The wave theory. Arch Derm 1998;134:142.
12. Whicher JT, Evans SW. Cytokines in disease. Clin Chem 1990;36:1269-81.
13. Philpott MP, Sanders DA, Bowen J, Kealey T. Effects of interleukins, colony-stimulating factor and tumor necrosis factor? in alopecia areata. Br J Dermatol 1996;135:942-8.
14. Hoffmann R, Eicheler W, Huth A, Wenzel E, Happle R. Cytokines and growth factors influence hair growth in vitro: Possible implications for the pathogenesis and treatment of alopecia areata. Arch Dermatol Res 1996;288:153-6. (Pubitemid 26093170)
15. Thein C, Strange P, Hansen ER, Baadsgaard O. Lesional alopecia areata T lymphocytes downregulate epithelial cell proliferation. Arch Dermatol Res 1997;289:384-8. (Pubitemid 27331331)
16. Teraki Y, Imanishi K, Shiohara T. Cytokines in alopecia areata: Contrasting cytokine profiles in localized form and extensive form (alopecia universalis). Acta Derm Venereol (Stockh) 1996;76:421-3. (Pubitemid 26398084)
17. Koubanova A, Gadjlgoroeva A. On the problem of pathogenetic heterogeneity of alopecia areata. EHRS Brussels, Conference abstracts; Jun 27-29, 2002. p. 13.
18. Lis A, Pierzchala E, Brzezinska-Wcislo L. The role of cellmediated immune response in pathogenesis of alopecia areata. Wiad Lek 2001;54:159-63.